Mira Pharmaceuticals: Director Brian Daly resigns; Michael Jerman becomes Audit Committee Chair

MIRA PHARMACEUTICALS, INC.

Brian Daly resigned from the Board effective December 1, 2023; he had served as Audit Committee Chair and Compensation Committee member.
Michael Jerman appointed Chairman of the Audit Committee on December 1, 2023; had been appointed to the committee on November 14, 2023.
Daly's resignation was not due to any disagreement with the Company, management, or Board on operations, policies, or practices.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brian Daly

Director

MIRA · MIRA PHARMACEUTICALS, INC.

Effective: 2023-12-01
Filed: December 1, 2023, 6:59 PM ET

on December 1, 2023, Brian Daly resigned from the Board of Directors of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian Daly resigned as Director at MIRA PHARMACEUTICALS, INC..

Action: resigned
Role: Director

Exact text from the filing

on December 1, 2023, Brian Daly resigned from the Board of Directors of the Company.

View on SEC.gov

MIRA PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001493152-23-043441

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.